ZNTL May 2024 15.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:12AM EDT. Market open.
| Previous Close | 0.2000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 15.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.1000 - 0.2000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 16 |
GlobeNewswireZentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that members of the management team will participate in a virtual fireside chat during the TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO and EHA on May 28, 2024 at 10:30 a.m. ET. Ac
Simply Wall St.Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
- GuruFocus.com
Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ...
Insight into Zentalis Pharmaceuticals' Financial Health and Future Outlook
© 2024 Yahoo. All rights reserved.